FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease
FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Ryoncil is the […]
Stem cell therapy found to boost fertility in women with ovarian failure
Stem cell therapy found to boost fertility in women with ovarian failure Stem cell treatment may be effective for fertility restoration in women with ovarian failure, according to a recent study published in Aging (Aging-US).1 This method was associated with a 70% oocyte activation rate and spontaneous pregnancy in 7% of participants. Additionally, 14% achieved pregnancy […]
Paralysed man stands again after receiving ‘reprogrammed’ stem cells
Paralysed man stands again after receiving ‘reprogrammed’ stem cells A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal-cord injury. The Japanese man was one of four individuals in a first-of-its-kind trial that used reprogrammed stem cells to treat people who are paralysed.
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease The FDA has approved the first – and only – treatment, a cell therapy, for macular telangiectasia type 2 (MacTel), a rare neurodegenerative disease that causes irreversible vision loss. The treatment, Encelto (revakinagene taroretcel-lwey), is an encapsulated cell therapy, developed by Neurotech Pharmaceuticals, that […]